Project Details
Description
Protocol GS-US-259-1890:A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ranolazine in Male Subjects with Duchenne Muscular Dystrophy (DMD) and Reduced Lower Extremity Function
| Status | Finished |
|---|---|
| Effective start/end date | 10/2/15 → 11/13/15 |
Funding
- GILEAD SCIENCES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.